InvestLog
ALLO logo

ALLO

Allogene Therapeutics, Inc.NASDAQHealthcare
$2.48+4.84%ClosedMarket Cap: $604.6M

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

14

Sales

11

Buy/Sell Ratio

1.27

Total Bought

$0.00

Total Sold

$11.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell2,867$2.50195,338
Wed Mar 18Chang David Ddirector, officer: President and CEOSell47,763$2.475,150,599
Wed Mar 18Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell4,835$2.47198,205
Wed Mar 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,132$2.60203,040
Wed Feb 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell7,549$1.73210,172
Wed Feb 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell105,720$0.00105,720
Wed Feb 04Chang David Ddirector, officer: President and CEOSell95,269$1.805,185,862
Wed Feb 04Beneski Benjamin Machinasofficer: SVP, Chief Technical OfficerSell373,757$1.87373,757
Wed Feb 04Chang David Ddirector, officer: President and CEOSell392,586$0.00392,586
Wed Feb 04Parker Geoffrey M.officer: CHIEF FINANCIAL OFFICERSell24,001$1.761,252,795
Wed Feb 04Chang David Ddirector, officer: President and CEOSell1,387,931$1.871,387,931